Advisor Group’s Dare Bioscience DARE Stock Holding History

Advisor Group’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-65	Closed	-$6K	–	4805
2017 Q1	$6K	Buy	+65	New	+$9.38K	﹤0.01%	4025

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Advisor Group's DARE Position: Q2 2017 in Review

Advisor Group sold out of Dare Bioscience (DARE) in Q2 2017, closing a stake of 65 shares — an estimated $6K sold.

Advisor Group first reported a position in DARE in Q1 2017 and held it in 1 quarter. The position peaked at $6K in Q1 2017. 19 funds tracked by Wall St. Rank hold DARE as of Q2 2017.

Advisor Group reported no remaining Dare Bioscience position as of Q2 2017 after selling out during the quarter.
Advisor Group sold 65 Dare Bioscience shares in Q2 2017, an estimated $6K.
Advisor Group first reported a position in Dare Bioscience in Q1 2017 and held it in 1 quarter.
Advisor Group's Dare Bioscience position peaked at $6K in Q1 2017.
19 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2017.

Based on Advisor Group's 13F filing for Q2 2017, filed 11 Aug 2017.